Literature DB >> 1139474

Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.

A Barbeau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1139474      PMCID： PMC1956240     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  [Long-term results of L-dopa treatment of parkinsonism].

Authors:  A Barbeau
Journal:  Union Med Can       Date:  1975-01

Review 2.  Parkinson's disease and levodopa. A five-year follow-up and review.

Authors:  C H Markham; L J Treciokas; S G Diamond
Journal:  West J Med       Date:  1974-09

3.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

4.  Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.

Authors:  Y Agid; F Javoy; J Glowinski
Journal:  Nat New Biol       Date:  1973-10-03

5.  Aromatic amino acids and modification of parkinsonism.

Authors:  G C Cotzias; M H Van Woert; L M Schiffer
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

8.  Excretion of dopamine in diseases of basal ganglia.

Authors:  A BARBEAU; G F MURPHY; T L SOURKES
Journal:  Science       Date:  1961-05-26       Impact factor: 47.728
  8 in total
  3 in total

Review 1.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease.

Authors:  J Guridi; R González-Redondo; J A Obeso
Journal:  Parkinsons Dis       Date:  2012-10-17

3.  Periodontal health and caries prevalence evaluation in patients affected by Parkinson's disease.

Authors:  Marco Cicciù; Giacomo Risitano; Giuseppe Lo Giudice; Ennio Bramanti
Journal:  Parkinsons Dis       Date:  2012-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.